- Home
- ETON vs MPU Comparison
ETON vs MPU Comparison
Compare ETON & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | MPU |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.8M | 89.5M |
| IPO Year | 2018 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ETON | MPU |
|---|---|---|
| Price | $15.94 | $1.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $29.67 | N/A |
| AVG Volume (30 Days) | ★ 277.8K | 181.0K |
| Earning Date | 11-06-2025 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,316,000.00 | $31,139,100.00 |
| Revenue This Year | $113.27 | N/A |
| Revenue Next Year | $36.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 102.77 | 19.98 |
| 52 Week Low | $11.09 | $0.49 |
| 52 Week High | $23.00 | $4.44 |
Technical Indicators
Market Signals| Indicator | ETON | MPU |
|---|---|---|
| Relative Strength Index (RSI) | 41.28 | 48.07 |
| Support Level | $16.13 | $1.28 |
| Resistance Level | $17.19 | $1.37 |
| Average True Range (ATR) | 0.73 | 0.12 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 32.98 | 40.48 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.